# Phio Pharmaceuticals Corp.: Form DEF 14A, filed Jun 30, 2022

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: DEF 14A
- Filed: 2022-06-30
- Accepted by EDGAR: Jun 30, 2022, 16:30 ET
- Period: 2022-08-09
- Accession: 0001683168-22-004728
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316822004728/phio_def14a-080922.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316822004728/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316822004728/phio_def14a-080922.htm

Filed Jun 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-004728. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
